153 related articles for article (PubMed ID: 18815538)
1. Effect of celecoxib and the novel anti-cancer agent, dimethylamino-parthenolide, in a developmental model of pancreatic cancer.
Yip-Schneider MT; Wu H; Njoku V; Ralstin M; Holcomb B; Crooks PA; Neelakantan S; Sweeney CJ; Schmidt CM
Pancreas; 2008 Oct; 37(3):e45-53. PubMed ID: 18815538
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide-donating aspirin prevents pancreatic cancer in a hamster tumor model.
Ouyang N; Williams JL; Tsioulias GJ; Gao J; Iatropoulos MJ; Kopelovich L; Kashfi K; Rigas B
Cancer Res; 2006 Apr; 66(8):4503-11. PubMed ID: 16618778
[TBL] [Abstract][Full Text] [Related]
3. Effect of celecoxib and novel agent LC-1 in a hamster model of lung cancer.
Vegeler RC; Yip-Schneider MT; Ralstin M; Wu H; Crooks PA; Neelakantan S; Nakshatri H; Sweeney CJ; Schmidt CM
J Surg Res; 2007 Nov; 143(1):169-76. PubMed ID: 17950089
[TBL] [Abstract][Full Text] [Related]
4. Treatment of N-nitrosobis(2-oxopropyl)amine-induced pancreatic cancer in Syrian golden hamsters with D-Trp-6-LH-RH and somatostatin analogue RC-160 microcapsules.
Zalatnai A; Schally AV
Cancer Res; 1989 Apr; 49(7):1810-5. PubMed ID: 2564312
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of dimethylaminoparthenolide and sulindac in combination with gemcitabine in a genetically engineered mouse model of pancreatic cancer.
Yip-Schneider MT; Wu H; Hruban RH; Lowy AM; Crooks PA; Schmidt CM
Pancreas; 2013 Jan; 42(1):160-7. PubMed ID: 22699205
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of cyclooxygenase-2 inhibition in an orthotopic murine model of lung cancer for dose-dependent effect.
Sievers EM; Bart RD; Backhus LM; Lin Y; Starnes M; Castanos R; Starnes VA; Bremner RM
J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1242-9. PubMed ID: 15942563
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the efficacy and safety of celecoxib 200 mg and celecoxib 400 mg once daily in treating the signs and symptoms of psoriatic arthritis.
Kivitz AJ; Espinoza LR; Sherrer YR; Liu-Dumaw M; West CR
Semin Arthritis Rheum; 2007 Dec; 37(3):164-73. PubMed ID: 17570469
[TBL] [Abstract][Full Text] [Related]
8. Exisulind in combination with celecoxib modulates epidermal growth factor receptor, cyclooxygenase-2, and cyclin D1 against prostate carcinogenesis: in vivo evidence.
Narayanan BA; Reddy BS; Bosland MC; Nargi D; Horton L; Randolph C; Narayanan NK
Clin Cancer Res; 2007 Oct; 13(19):5965-73. PubMed ID: 17908994
[TBL] [Abstract][Full Text] [Related]
9. Celecoxib potentiates the anticancer effect of cisplatin on vulvar cancer cells independently of cyclooxygenase.
Kim SH; Kim SH; Song YC; Song YS
Ann N Y Acad Sci; 2009 Aug; 1171():635-41. PubMed ID: 19723114
[TBL] [Abstract][Full Text] [Related]
10. A novel combination therapy with arsenic trioxide and parthenolide against pancreatic cancer cells.
Wang W; Adachi M; Zhang R; Zhou J; Zhu D
Pancreas; 2009 May; 38(4):e114-23. PubMed ID: 19342982
[TBL] [Abstract][Full Text] [Related]
11. Melatonin and celecoxib improve the outcomes in hamsters with experimental pancreatic cancer.
Padillo FJ; Ruiz-Rabelo JF; Cruz A; Perea MD; Tasset I; Montilla P; Túnez I; Muntané J
J Pineal Res; 2010 Oct; 49(3):264-70. PubMed ID: 20626589
[TBL] [Abstract][Full Text] [Related]
12. Suppression of N-nitrosobis(2-oxopropyl)amine-induced pancreatic carcinogenesis in hamsters by pioglitazone, a ligand of peroxisome proliferator-activated receptor gamma.
Takeuchi Y; Takahashi M; Sakano K; Mutoh M; Niho N; Yamamoto M; Sato H; Sugimura T; Wakabayashi K
Carcinogenesis; 2007 Aug; 28(8):1692-6. PubMed ID: 17449904
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of protocatechuic acid on the post-initiation phase of hamster pancreatic carcinogenesis induced by N-nitrosobis(2-oxopropyl)amine.
Nakamura H; Nishikawa A; Furukawa F; Kasahara K; Miyauchi M; Son HY; Hirose M
Anticancer Res; 2000; 20(5B):3423-7. PubMed ID: 11131643
[TBL] [Abstract][Full Text] [Related]
14. Perioperative cyclooxygenase 2 inhibition to reduce tumor cell adhesion and metastatic potential of circulating tumor cells in non-small cell lung cancer.
Backhus LM; Sievers E; Lin GY; Castanos R; Bart RD; Starnes VA; Bremner RM
J Thorac Cardiovasc Surg; 2006 Aug; 132(2):297-303. PubMed ID: 16872953
[TBL] [Abstract][Full Text] [Related]
15. The effect of celecoxib on tissue factor expression in pancreatic cancer cells.
Wang HY; Yang YM; Zhuang Y; Chen HN; Wan YL; Huang YT
Chin Med J (Engl); 2007 Oct; 120(20):1753-6. PubMed ID: 18028765
[TBL] [Abstract][Full Text] [Related]
16. Chemopreventative effect of a cyclooxygenase-2-specific inhibitor (etodolac) on chemically induced biliary carcinogenesis in hamsters.
Tsuneoka N; Tajima Y; Kitazato A; Fukuda K; Kitajima T; Kuroki T; Onizuka S; Kanematsu T
Carcinogenesis; 2005 Feb; 26(2):465-9. PubMed ID: 15498790
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of inducible nitric oxide synthase (iNOS) in N-nitrosobis(2-oxopropyl)amine-induced hamster pancreatic carcinogenesis and prevention of cancer development by ONO-1714, an iNOS inhibitor.
Takahashi M; Kitahashi T; Ishigamori R; Mutoh M; Komiya M; Sato H; Kamanaka Y; Naka M; Maruyama T; Sugimura T; Wakabayashi K
Carcinogenesis; 2008 Aug; 29(8):1608-13. PubMed ID: 18567618
[TBL] [Abstract][Full Text] [Related]
18. Bile-reflux into the pancreatic ducts is associated with the development of intraductal papillary carcinoma in hamsters.
Adachi T; Tajima Y; Kuroki T; Mishima T; Kitasato A; Fukuda K; Tsutsumi R; Kanematsu T
J Surg Res; 2006 Nov; 136(1):106-11. PubMed ID: 16863651
[TBL] [Abstract][Full Text] [Related]
19. Modification of pancreatic carcinogenesis in the hamster model. XII. Dose-related effect of ethanol.
Pour PM; Reber HA; Stepan K
J Natl Cancer Inst; 1983 Nov; 71(5):1085-7. PubMed ID: 6316010
[TBL] [Abstract][Full Text] [Related]
20. Celecoxib prevents neuroblastoma tumor development and potentiates the effect of chemotherapeutic drugs in vitro and in vivo.
Ponthan F; Wickström M; Gleissman H; Fuskevåg OM; Segerström L; Sveinbjörnsson B; Redfern CP; Eksborg S; Kogner P; Johnsen JI
Clin Cancer Res; 2007 Feb; 13(3):1036-44. PubMed ID: 17289900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
